A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Compare Pharmacokinetics, Pharmacodynamics and Safety After Single/ Multiple Administration of CKD-382 and D026 in Healthy Subjects
Latest Information Update: 05 Jan 2023
At a glance
- Drugs CKD 382 (Primary) ; D 026 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Chong Kun Dang
- 14 Jan 2021 New trial record